Nagoya, Japan

Kei Muto

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nagoya University. Active years: 2015.


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kei Muto: Innovator in Heterocyclic Derivatives

Introduction

Kei Muto is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of chemistry, particularly in the production of phenyl-substituted heterocyclic derivatives. His innovative methods have the potential to impact various applications in pharmaceuticals and materials science.

Latest Patents

Muto holds a patent for a method for producing a phenyl-substituted heterocyclic derivative. This invention involves a process where a heteroaromatic compound is reacted with a phenol derivative in the presence of a nickel compound, 1,2-bis(dicyclohexylphosphino)ethane, and a base. This method is represented by general formula (1) and showcases Muto's expertise in synthetic chemistry.

Career Highlights

Kei Muto is affiliated with Nagoya University, where he conducts research and develops innovative chemical processes. His work has garnered attention for its practical applications and scientific rigor. Muto's dedication to advancing chemical methodologies has established him as a respected figure in his field.

Collaborations

Muto has collaborated with notable colleagues, including Kenichiro Itami and Junichiro Yamaguchi. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their respective areas of expertise.

Conclusion

Kei Muto's contributions to the field of chemistry, particularly through his patented methods, highlight his role as an influential inventor. His work continues to inspire advancements in the production of heterocyclic compounds, showcasing the importance of innovation in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…